Coexpression of preprotachykinin A and B transcripts in the bovine corpus luteum and evidence for functional neurokinin receptor activity in luteal endothelial cells and ovarian macrophages

[1]  P. Huber,et al.  Cytokeratin expression in bovine corpora lutea , 1995, Histochemistry and Cell Biology.

[2]  K. Spanel‐Borowski,et al.  Transcripts of neurokinin B and neurokinin 3 receptor in superovulated rat ovaries and increased number of corpora lutea as a non-specific effect of intraperitoneal agonist application , 2004, Regulatory Peptides.

[3]  S. Hunt,et al.  Increased formation of corpora lutea in neurokinin 1‐receptor deficient mice , 2004, Molecular reproduction and development.

[4]  B. Rueda,et al.  Microvascular endothelial cells of the corpus luteum , 2003, Reproductive biology and endocrinology : RB&E.

[5]  K. Spanel‐Borowski,et al.  Pregnancy-induced changes in substance P and neurokinin 1 receptor (NK1-R) expression in the rat uterus. , 2003, Reproduction.

[6]  M. Candenas,et al.  A Role for Tachykinins in Female Mouse and Rat Reproductive Function1 , 2003, Biology of reproduction.

[7]  H. Minakata,et al.  Insight into Tachykinin-Related Peptides, Their Receptors, and Invertebrate Tachykinins: A review , 2003, Zoological science.

[8]  S. Gardiner,et al.  Characterization of the endokinins: Human tachykinins with cardiovascular activity , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[9]  G. Hamlin,et al.  Estrogen-Dependent Regulation of Neurokinin 3 Receptor-Mediated Uterine Contractility in the Rat1 , 2002, Biology of reproduction.

[10]  S. Böckmann.  Substance P (NK1) receptor expression by human colonic epithelial cell line Caco-2 , 2002, Peptides.

[11]  M. Brännström,et al.  Leukocyte networks and ovulation. , 2002, Journal of reproductive immunology.

[12]  C. Austin,et al.  Identification, localization and receptor characterization of novel mammalian substance P-like peptides. , 2002, Gene.

[13]  P. Nieto,et al.  Changes in the Expression of Tachykinin Receptors in the Rat Uterus During the Course of Pregnancy1 , 2001, Biology of reproduction.

[14]  P. Lowry,et al.  A regulatory role for neurokinin B in placental physiology and pre-eclampsia , 2001, Regulatory Peptides.

[15]  G. Aust,et al.  The expression of substance P and its neurokinin-1 receptor mRNA in the bovine corpus luteum of early developmental stage , 2001, Neuroscience Letters.

[16]  EN Patak,et al.  Effects Of Tachykinins On Uterine Smooth Muscle , 2000, Clinical and experimental pharmacology & physiology.

[17]  Gillian E. Wu,et al.  Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis , 2000, Nature Immunology.

[18]  C. Maggi,et al.  Peripheral actions of tachykinins , 2000, Neuropeptides.

[19]  J. Calixto,et al.  Neurokinin mediation of edema and inflammation , 2000, Neuropeptides.

[20]  C. Maggi.  Principles of tachykininergic co-transmission in the peripheral and enteric nervous system , 2000, Regulatory Peptides.

[21]  S. Gardiner,et al.  Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia , 2000, Nature.

[22]  G. Hamlin,et al.  Hormonal Variation of Rat Uterine Contractile Responsiveness to Selective Neurokinin Receptor Agonists1 , 2000, Biology of reproduction.

[23]  K. Spanel‐Borowski,et al.  Difference in localization of eosinophils and mast cells in the bovine ovary , 2000 .

[24]  P. Rameshwar,et al.  Increased expression of preprotachykinin-I and neurokinin receptors in human breast cancer cells: implications for bone marrow metastasis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[25]  G. Aust,et al.  Cloning of bovine RANTES mRNA and its expression and regulation in ovaries in the periovulatory period , 1999, FEBS letters.

[26]  J. Olerud,et al.  VCAM-1 expression on human dermal microvascular endothelial cells is directly and specifically up-regulated by substance P. , 1999, Journal of immunology.

[27]  J. Olerud,et al.  Neuropeptide regulation of human dermal microvascular endothelial cell ICAM-1 expression and function. , 1998, American journal of physiology. Cell physiology.

[28]  W. Ho,et al.  Human lymphocytes express substance P and its receptor , 1998, Journal of Neuroimmunology.

[29]  K. Spanel‐Borowski,et al.  Immunolocalization of CD18-positive cells in the bovine ovary. , 1997, Journal of reproduction and fertility.

[30]  C. Maggi.  The effects of tachykinins on inflammatory and immune cells , 1997, Regulatory Peptides.

[31]  H. Sarau,et al.  Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 1. Identification of the 4-quinolinecarboxamide framework. , 1997, Journal of medicinal chemistry.

[32]  K. Spanel‐Borowski,et al.  Evidence for the maintenance of macrophage-like cells in long-term bovine granulosa cell cultures , 1997, Cell and Tissue Research.

[33]  S. Fukuhara,et al.  Further Identification of Neurokinin Receptor Types and Mechanisms of Calcium Signaling Evoked by Neurokinins in the Murine Neuroblastoma C1300 Cell Line , 1996, Journal of neurochemistry.

[34]  W. Scherbaum,et al.  Different cytokine mRNA profiles in Graves' disease, Hashimoto's thyroiditis, and nonautoimmune thyroid disorders determined by quantitative reverse transcriptase polymerase chain reaction (RT-PCR). , 1996, Thyroid : official journal of the American Thyroid Association.

[35]  C. Wiedermann,et al.  Induction of endothelial cell differentiation into capillary-like structures by substance P. , 1996, European journal of pharmacology.

[36]  C. Maggi,et al.  Tachykinin receptors and receptor subtypes. , 1995, Archives internationales de pharmacodynamie et de therapie.

[37]  C. Murphy,et al.  Growth-promoting effects of substance P on endothelial cells in vitro. Synergism with calcitonin gene-related peptide, insulin, and plasma factors. , 1994, Circulation research.

[38]  D. Schams,et al.  Multiple effects of neuropeptide Y, substance P and vasoactive intestinal polypeptide on progesterone and oxytocin release from bovine corpus luteum in vitro. , 1993, The Journal of endocrinology.

[39]  C. Strader,et al.  Determination of the amino acid residues in substance P conferring selectivity and specificity for the rat neurokinin receptors. , 1992, Molecular pharmacology.

[40]  R. A. Akhtar,et al.  Species differences in the effects of substance P on inositol trisphosphate accumulation and cyclic AMP formation, and on contraction in isolated iris sphincter of the mammalian eye: differences in receptor density. , 1991, Experimental eye research.

[41]  S. Nakanishi,et al.  Molecular Characterization of the Three Tachykinin Receptors , 1991, Annals of the New York Academy of Sciences.

[42]  F. Nantel,et al.  Neurokinin Agonists and Antagonists , 1991, Annals of the New York Academy of Sciences.

[43]  H. Jarry,et al.  Effects of substance-P and neuropeptide-Y on in vitro steroid release by porcine granulosa and luteal cells. , 1991, Endocrinology.

[44]  W. Schulze,et al.  Tachykinin (substance-P) gene expression in Leydig cells of the human and mouse testis. , 1991, Endocrinology.

[45]  C. Maggi,et al.  Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells. , 1990, Microvascular research.

[46]  K. Spanel‐Borowski,et al.  Different phenotypes of cultured microvessel endothelial cells obtained from bovine corpus luteum. Study by light microscopy and by scanning electron microscopy (SEM). , 1990, Cell and tissue research.

[47]  M. Moskowitz,et al.  Identification of immunoreactive substance P in human and other mammalian endothelial cells , 1989, Peptides.

[48]  R. Laufer,et al.  [pGlu6,Pro9]SP6-11, a selective agonist for the substance P P-receptor subtype. , 1986, Journal of medicinal chemistry.

[49]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.